Maryam Bakherad1, Mahdieh Salimi2, Seyed Abdolhamid Angaji1, Frouzandeh Mahjoubi3, Tayebeh Majidizadeh3. 1. Department of Cell and Molecular Biology, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran. 2. Department of Medical Biotechnology, National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran. salimi@nigeb.ac.ir. 3. Department of Medical Biotechnology, National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran.
Abstract
BACKGROUND: To make the right treatment decisions about colorectal cancer (CRC) patients reliable predictive and prognostic data are needed. However, in many cases this data is not enough. Some studies suggest that LRIG1 gene (leucine-rich repeats and immunoglobulin-like domains1) has prognostic implications in different kinds of cancers. METHODS: One hundred and two patients with colorectal cancer were retrospectively analyzed for LRIG1 expression at both mRNA and protein levels. SYBR Green Real-Time RT-PCR technique was used for mRNA expression analyses and Glyceraldehyde-3-Phosphate Dehydrogenase gene (GAPDH) was considered as a reference gene for data normalization. LRIG1 protein expression was analyzed using Immunohistochemistry. Additionally, appropriate statistic analyses were used to assess the expression of LRIG1 in test and control groups. The prognostic significance of LRIG1 expression was analyzed using the univariate and multivariate analyses. RESULTS: The data revealed that the expression of LRIG1 in both mRNA and protein levels was down regulated in colorectal tumor tissues (P < 0.01) but is not clinically relevant prognostic indicator in CRC. CONCLUSIONS: Therefore, it is suggested that LRIG1 expression analyses may not be considered as an important issue when making informed and individualized clinical decisions regarding the management of colorectal cancer patients.
BACKGROUND: To make the right treatment decisions about colorectal cancer (CRC) patients reliable predictive and prognostic data are needed. However, in many cases this data is not enough. Some studies suggest that LRIG1 gene (leucine-rich repeats and immunoglobulin-like domains1) has prognostic implications in different kinds of cancers. METHODS: One hundred and two patients with colorectal cancer were retrospectively analyzed for LRIG1 expression at both mRNA and protein levels. SYBR Green Real-Time RT-PCR technique was used for mRNA expression analyses and Glyceraldehyde-3-Phosphate Dehydrogenase gene (GAPDH) was considered as a reference gene for data normalization. LRIG1 protein expression was analyzed using Immunohistochemistry. Additionally, appropriate statistic analyses were used to assess the expression of LRIG1 in test and control groups. The prognostic significance of LRIG1 expression was analyzed using the univariate and multivariate analyses. RESULTS: The data revealed that the expression of LRIG1 in both mRNA and protein levels was down regulated in colorectal tumor tissues (P < 0.01) but is not clinically relevant prognostic indicator in CRC. CONCLUSIONS: Therefore, it is suggested that LRIG1 expression analyses may not be considered as an important issue when making informed and individualized clinical decisions regarding the management of colorectal cancerpatients.
Authors: Eunyoung Choi; Tyler L Lantz; Gregory Vlacich; Theresa M Keeley; Linda C Samuelson; Robert J Coffey; James R Goldenring; Anne E Powell Journal: Gut Date: 2017-08-16 Impact factor: 23.059
Authors: Marcus Thomasson; Baofeng Wang; Peter Hammarsten; Anna Dahlman; Jenny Liao Persson; Andreas Josefsson; Pär Stattin; Torvald Granfors; Lars Egevad; Roger Henriksson; Anders Bergh; Håkan Hedman Journal: Int J Cancer Date: 2011-04-08 Impact factor: 7.396
Authors: E Missiaglia; B Jacobs; G D'Ario; A F Di Narzo; C Soneson; E Budinska; V Popovici; L Vecchione; S Gerster; P Yan; A D Roth; D Klingbiel; F T Bosman; M Delorenzi; S Tejpar Journal: Ann Oncol Date: 2014-07-23 Impact factor: 32.976
Authors: A K Lindström; K Ekman; U Stendahl; T Tot; R Henriksson; H Hedman; D Hellberg Journal: Int J Gynecol Cancer Date: 2007-07-11 Impact factor: 3.437
Authors: Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal Journal: CA Cancer J Clin Date: 2018-09-12 Impact factor: 508.702
Authors: Kim B Jensen; Charlotte A Collins; Elisabete Nascimento; David W Tan; Michaela Frye; Satoshi Itami; Fiona M Watt Journal: Cell Stem Cell Date: 2009-05-08 Impact factor: 24.633
Authors: Patricia A Thompson; Ingrid Ljuslinder; Spyros Tsavachidis; Abenaa Brewster; Aysegul Sahin; Håkan Hedman; Roger Henriksson; Melissa L Bondy; Beatrice S Melin Journal: Cancer Res Date: 2014-06-01 Impact factor: 12.701